Microbix Biosystems Inc
TSX:MBXView on OTCQX International

  • LAST PRICE
    0.3100
  • TODAY'S CHANGE (%)
    0.0100 (3.3333%)
  • Bid / Lots
    0.3100/ 31
  • Ask / Lots
    0.3150/ 1
  • Open / Previous Close
    0.3000 / 0.3000
  • Day Range
    0.2950
    0.3100
  • 52 Week Range
    0.2800
    0.4500
  • Volume
    31,500

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 12, 2024

      Show headlines and story abstract

    • 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
      Companies Mentioned: MBX, MBXBF

      KOL Collaborators Present Microbix HPV Test-Control Results

      Validation for use with Self-Collected Samples across Multiple Assays and Media

      MISSISSAUGA, Ontario, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R) ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader ("KOL") collaborators are presenting results of a Microbix Quality Assessment Product ("QAP(TM)") for controlling testing for high-risk types of Human Papilloma Virus ("HPV") at the 36(th) annual International Papillomavirus Conference ("IPVC") taking place in Edinburgh, Scotland, November 12 to 15, 2024.

Peers Headlines